651 filings
Page 7 of 33
8-K
2nyz838wjc64ixfdbhh
19 Nov 20
Regulation FD Disclosure
11:34am
8-K
osymnpgb015jbd1q02
12 Nov 20
Vaxart Reports Third Quarter 2020 Financial Results and Provides Business Update
4:03pm
8-K
cgnxnxr8hy9j1
14 Oct 20
Entry into a Material Definitive Agreement
6:04am
424B5
j8jbxs3xzg70
13 Oct 20
Prospectus supplement for primary offering
5:27pm
8-K
ror sgpr65m2cih
8 Oct 20
Entry into a Material Definitive Agreement
3:40pm
8-K
4nl0ow cnbycu0
23 Sep 20
Regulation FD Disclosure
1:15pm
8-K
bq631 lx8kpojyn8
15 Sep 20
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
12:00am
8-K
t8wvra2uvy
27 Aug 20
Vaxart Appoints Karen J. Wilson to its Board of Directors
8:09am
8-K
8e86y4j8t2fscuin060
6 Aug 20
Vaxart Announces Second Quarter 2020 Results
4:07pm
8-K
09srqw66enhluoux4q
13 Jul 20
Other Events
4:13pm
8-K
syvtk7 u5p24iuge9v9
8 Jul 20
Results of Operations and Financial Condition
8:51am
S-3ASR
rfny7019l0zgjthdyplb
8 Jul 20
Automatic shelf registration
8:50am
S-8
k8a 1mcq3lycjmj8yz49
7 Jul 20
Registration of securities for employees
4:20pm
8-K
3sk4fso teah3boojbth
30 Jun 20
Vaxart, Inc. Signs Memorandum of Understanding with Attwill Medical Solutions Sterilflow, LP
5:24pm
8-K
u7v1t5
23 Jun 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:24pm
8-K
8c3 egqsisd1iusc
18 Jun 20
Regulation FD Disclosure
1:26pm
8-K
7ggxt8szwoxckdg
15 Jun 20
Vaxart, Inc. Appoints New CEO to Accelerate Advancement of COVID-19 and Other Programs
5:25pm
8-K
4x2k pjyidcf00u
9 Jun 20
Departure of Directors or Certain Officers
4:26pm